BRIEF published on 04/08/2024 at 23:25, 1 year 8 months ago Ur-Energy Inc. accueille de nouveaux membres du conseil d'administration et annonce de prochains départs à la retraite Gouvernance D'Entreprise Leadership Executif Ur-Énergie Inc. Nouveaux Membres Du Conseil D'administration Pouvoir Nucléaire
BRIEF published on 04/08/2024 at 23:20, 1 year 8 months ago Data4Cure to Present Key Research at AACR 2024 Cancer Research Immunotherapy AACR 2024 Data4Cure Biomedical Data
BRIEF published on 04/08/2024 at 23:20, 1 year 8 months ago Data4Cure présentera des recherches clés à l'AACR 2024 Immunothérapie Recherche Contre Le Cancer RCAA 2024 Data4Cure Données Biomédicales
BRIEF published on 04/08/2024 at 23:17, 1 year 8 months ago Biophytis Reports 2023 Financial Results and Business Updates Biophytis Financial Results 2023 Sarcopenia BIO101 COVID-19 Treatment
BRIEF published on 04/08/2024 at 23:17, 1 year 8 months ago Biophytis annonce ses résultats financiers pour 2023 et actualise sur ses activités Biophytis Résultats Financiers 2023 Programmes Cliniques BIO101 Sarcopénie Et COVID-19
BRIEF published on 04/08/2024 at 23:15, 1 year 8 months ago Biophytis Initiates Phase 2 Clinical Study for Obesity Treatment with BIO101 Biophytis Obesity Treatment BIO101 GLP-1 Receptor Agonists OBA Phase 2 Study
BRIEF published on 04/08/2024 at 23:15, 1 year 8 months ago Biophytis annonce le lancement de l'étude clinique de phase 2 OBA pour le traitement de l'obésité Biophytis Santé Étude Clinique BIO101 Obésité
BRIEF published on 04/08/2024 at 23:09, 1 year 8 months ago Biophytis annonce ses résultats financiers 2023 et fait le point sur ses activités Biophytis Financement Développement Clinique Résultats Financiers 2023 BIO101
BRIEF published on 04/08/2024 at 23:09, 1 year 8 months ago Biophytis announces its 2023 financial results and provides an update on its activities Biophytis Funding Clinical Development 2023 Financial Results BIO101
BRIEF published on 04/08/2024 at 23:05, 1 year 8 months ago Biophytis Announces Phase 2 Clinical Study in Obesity Treatment with BIO101 Biophytis Obesity Treatment BIO101 OBA Phase 2 Clinical Study GLP-1 Receptor Agonists
Published on 12/20/2025 at 00:30, 2 days 7 hours ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 2 days 9 hours ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 13 hours ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 17 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 2 days 18 hours ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/22/2025 at 07:00, 39 minutes ago VIB Vermögen AG sells logistics property in Großmehring
Published on 12/22/2025 at 04:30, 3 hours 9 minutes ago DFSK Officially Enters the Egyptian Market with Strategic Vehicle Lineup
Published on 12/22/2025 at 00:35, 7 hours 4 minutes ago Samsung to Host Series of Tech Forums at CES 2026
Published on 12/22/2025 at 00:05, 7 hours 34 minutes ago Samsung To Unveil AI Vision Built With Google Gemini at CES 2026
Published on 12/21/2025 at 08:55, 22 hours 44 minutes ago Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Published on 12/19/2025 at 21:57, 2 days 9 hours ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 2 days 23 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 2 days 23 hours ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 3 days ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 3 days ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
